November 21, 2006Annals of Internal Medicine

Low-Molecular-Weight Heparin and Bleeding: How Do We Lower Risk but Maintain Benefit?

View Full Paper

Ask AI

Bookmark

Why the study?

Do standard doses of enoxaparin increase the risk of major bleeding in patients with severe renal insufficiency?

Population

Patients with severe renal insufficiency

Design

Editorial

Authors

TDT. S. DharmarajanTexas Tech University ASAmit SohagiaCommunity Medical Center

Discussion

Member takes

Implication

This letter highlights the importance of dose adjustment for enoxaparin in patients with severe renal impairment to mitigate the increased risk of major bleeding.

Structured PICO

Do standard doses of enoxaparin increase the risk of major bleeding in patients with severe renal insufficiency?

Population

Patients with severe renal insufficiency

Intervention

Standard doses of enoxaparin

Outcome

Major bleedingsafety

This letter highlights the importance of dose adjustment for enoxaparin in patients with severe renal impairment to mitigate the increased risk of major bleeding.

Cite This Study

Dharmarajan et al. (2006) studied this question.

synapsesocial.com/papers/6a7cc1817c12ccfc2577157b https://doi.org/10.7326/0003-4819-145-10-200611210-00018

Topics

Anticoagulation in AF

View Full Paper

Ask AI

Bookmark

Implication

This letter highlights the importance of dose adjustment for enoxaparin in patients with severe renal impairment to mitigate the increased risk of major bleeding.

Low-Molecular-Weight Heparin and Bleeding: How Do We Lower Risk but Maintain Benefit?

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

Low-Molecular-Weight Heparin and Bleeding: How Do We Lower Risk but Maintain Benefit?

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider